Latest News

What You Need to Know About Johnson & Johnson's 2020 First-Quarter Earnings

Chairman and CEO Alex Gorsky Profiled by the Financial Times About Johnson & Johnson's Work on a Potential Covid-19 Vaccine

5 Impactful Ways Johnson & Johnson Is Helping in the Fight Against Covid-19

A collage of photos of healthcare providers and a scientist working on Covid-19

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson Announces a $50 Million Commitment to Support Frontline Health Workers Battling Covid-19

Learn More

Featured Stories

March 30, 2020

"I Have Never Seen a Moment So Rich in Collaboration, Ingenuity and Acts of Bravery": Johnson & Johnson Announces It Has Identified a Lead Covid-19 Vaccine Candidate

ON NOW

March 19, 2020

What You Need to Know About How Johnson & Johnson's Supply Chain Is Responding to the Covid-19 Pandemic

ON NOW

A collage of photos of Johnson & Johnson supply chain employees

March 16, 2020

Lack of evidence to support use of darunavir-based treatments for SARS-CoV-2

ON NOW

January 28, 2020

What You Need to Know About the Coronavirus—and a Potential Preventive Vaccine

ON NOW

January 21, 2020

Johnson & Johnson Named a 2020 Fortune World’s Most Admired Company

ON NOW

Collage depicting innovations from Johnson & Johnson around Ebola, bladder cancer, HIV and more

January 15, 2020

Johnson & Johnson Pledges $600,000 in Disaster Relief in Response to the Bushfire Crisis in Australia

ON NOW

Croajingolong National Park, which has been affected by the Australia bushfires

See All Stories

School-age members of a program that aims to reduce HIV infections among young women in sub-Saharan Africa

365 Days of Caring: 13 Ways Johnson & Johnson Helped Progress Health for Humanity in 2018

Read the Story

The Quest for a Global Preventive HIV Vaccine Reaches an Exciting Milestone With the Mosaico Study

Read the Story

Combating Ebola: How a Johnson & Johnson Vaccine Is Helping in the Fight

Read the Story

More from Johnson & Johnson

Innovation

Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.

She's a Scientist with One of the World's Most Important Jobs: Creating a Potential Covid-19 Vaccine

ON NOW

Hanneke Schuitemaker, Ph.D., Global Head of Viral Vaccine Discovery and Translational Medicine and the Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention, a Janssen Pharmaceutical Company of Johnson & Johnson

Personal Stories

When Melissa Surdez received an urgent call from her physician sister who was battling the pandemic on the front lines in New Jersey and facing a mask shortage, she promised to help—and tapped Johnson & Johnson's thousands of employees to join her cause.

Caring on the Covid-19 Front Lines: "I Rallied Colleagues All Over the World to Help Me Make Over 1,000 Cloth Masks"

ON NOW

A photo of cloth face masks and Melissa Surdez with her sister Dr. Jessica Israel

Innovation

Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.

"I'm Racing to Screen Thousands of Molecules": These Scientists Are Canvassing a Vast Library in Search of a Potential Covid-19 Treatment

ON NOW